Sarepta Therapeutics Inc (NASDAQ:SRPT)

159.33
Delayed Data
As of Aug 05
 +2.16 / +1.38%
Today’s Change
72.05
Today|||52-Week Range
175.00
+23.47%
Year-to-Date
Personalis: Buy This Disruptor In Precision Medicine And Machine Learning
Jul 27 / Seeking Alpha - Paid Partner Content
Sarepta gene therapy Fast Track'd for Duchenne muscular dystrophy
Jul 24 / Seeking Alpha - Paid Partner Content
Rising Risk? Here's What You Can Buy
Jul 24 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close156.73
Today’s open156.91
Day’s range154.07 - 159.50
Volume571,072
Average volume (3 months)860,525
Market cap$12.0B
Data as of 3:59pm ET, 08/05/2020

Growth & Valuation

Earnings growth (last year)-77.81%
Earnings growth (this year)+52.13%
Earnings growth (next 5 years)+163.34%
Revenue growth (last year)+26.51%
P/E ratioNM
Price/Sales24.94
Price/Book14.09

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+1.90+1.00%
HZNPHorizon Therapeutics...+14.59+23.61%
RDYDr.Reddy's Laborator...-0.01-0.02%
CTLTCatalent Inc+1.44+1.63%
Data as of 4:33pm ET, 08/05/2020

Financials

Last reporting dateAugust 6, 2020
EPS forecast (this quarter)-$1.72
Annual revenue (last year)$380.8M
Annual profit (last year)-$715.1M
Net profit margin-187.77%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts